2016
DOI: 10.1016/j.rbre.2016.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findings

Abstract: The present study provides novel evidence demonstrating that low levels of 25OHD have a negative impact in diffuse SSc QoL and further studies are needed to define whether vitamin D supplementation can improve health related QoL in these patients. The additional observation of a correlation with severe NC alterations suggests a possible role of 25OHD in the underlying SSc vascular involvement.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
21
1
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(26 citation statements)
references
References 40 publications
2
21
1
2
Order By: Relevance
“…It is worth noticing that Park et al showed in a cross‐sectional study that patients with vitamin D deficiency had more frequent DUs over time, that is active or previous. Recently, Trombetta et al have shown that vitamin D serum levels negatively correlated with Medsger's score for peripheral vascular involvement and some other studies showed that lower levels of vitamin D were found in late‐pattern nerve conduction velocity. Taken together these data suggest that low vitamin D serum levels may actually affect microvascular manifestations of SSc, leading to an increased risk of developing DUs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is worth noticing that Park et al showed in a cross‐sectional study that patients with vitamin D deficiency had more frequent DUs over time, that is active or previous. Recently, Trombetta et al have shown that vitamin D serum levels negatively correlated with Medsger's score for peripheral vascular involvement and some other studies showed that lower levels of vitamin D were found in late‐pattern nerve conduction velocity. Taken together these data suggest that low vitamin D serum levels may actually affect microvascular manifestations of SSc, leading to an increased risk of developing DUs.…”
Section: Discussionmentioning
confidence: 99%
“…Vitamin D is able to influence the immune response; its role has been proven in different settings and it has been studied also in SSc. In particular, low levels have been reported in the literature with a prevalence of insufficiency even higher than 80% and of deficiency higher than 20% and its deficiency has been related to some disease manifestations, such as poor quality of life, low diffusing capacity for carbon monoxide (DLCO), diastolic dysfunction, digital contractures, advanced skin fibrosis, long disease duration, high values of C‐reactive protein and erythrocyte sedimentation rate, high pulmonary arterial pressure at echocardiography, lung involvement, kidney and gastrointestinal Medsger's severity score parameters and high disease activity . In particular, an association with microvascular involvement has been found as shown by the link with avascular areas at nailfold videocapillaroscopy (NVC), peripheral vascular Medsger's severity score parameters and DU development .…”
Section: Introductionmentioning
confidence: 99%
“…A recent study showed that low serum concentrations of 25(OH)D has negative impact in diffuse SSc patients’ quality of life and in addition, a correlation with severe NVC alterations was reported, suggesting a possible role of 25(OH)D in vascular involvement [18]. Furthermore, recently a significant difference in serum IgM anti-vitamin D antibodies in SSc patients was found, compared to healthy controls [19].…”
Section: Discussionmentioning
confidence: 99%
“…Ele intensifica-se com situações de estresse e de frio, produzindo agravos como isquemias e ulcerações digitais e necrose tecidual. Ainda, estes indivíduos apresentam deficiência de vitamina D, o que pode interferir em aspectos como a qualidade de vida e a capacidade de produzir uma FPP de boa qualidade (JORGE;SCHNORNBERGER;SANTOS, 2017;KAYSER;CORRÊA;ANDRADE, 2009;MACHADO;SOUTO;FREIRE, 2014;SAMPAIO-BARROS et al, 2016). Neste estudo os sujeitos com esclerose sistêmica não demonstraram melhora estatisticamente significativa nas avaliações pré e pós intervenção, possivelmente em virtude dos períodos de exacerbação do Fenômeno de Raynoud apresentado por estes.…”
Section: Resultsunclassified